Evan David Seigerman

Amgen, Inc. (NASDAQ: AMGN) shares have been in focus amid developments in the AI-powered healthcare space. The company’s oral and injectable metabolic pipeline gives investors exposure to the obesity metabolic space at a much lower premium than peers, according to BMO Capital Markets. The...

Danish pharma giant Novo Nordisk A/S (NYSE:NVO) is due to announce results from a late-stage trial, dubbed SELECT, that evaluates its semaglutide, sold under the brand name Wegovy, for the reduction of cardiovascular events in overweight or obese non-diabetic patients with prior cardiovascular...